vs
COMPASS MINERALS INTERNATIONAL INC（CMP）与Kiniksa Pharmaceuticals International, plc（KNSA）财务数据对比。点击上方公司名可切换其他公司
COMPASS MINERALS INTERNATIONAL INC的季度营收约是Kiniksa Pharmaceuticals International, plc的2.0倍（$396.1M vs $202.1M），Kiniksa Pharmaceuticals International, plc净利率更高（7.0% vs 4.7%，领先2.3%），Kiniksa Pharmaceuticals International, plc同比增速更快（65.0% vs 28.9%），Kiniksa Pharmaceuticals International, plc自由现金流更多（$53.3M vs $-59.8M），过去两年Kiniksa Pharmaceuticals International, plc的营收复合增速更高（59.1% vs 4.3%）
指南针矿产国际是一家美国上市矿产企业，总部位于堪萨斯州欧弗兰帕克，是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐，同时向全球种植者提供植物营养产品，此外也生产民用除冰、水质调节产品及相关商用产品。
Kiniksa Pharmaceuticals International plc是一家全球性生物制药企业，专注于发现、开发和商业化针对自身免疫性疾病、炎症性疾病及罕见病的靶向治疗药物，服务北美、欧洲、亚洲等主要市场的未被满足的临床需求。
CMP vs KNSA — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $396.1M | $202.1M |
| 净利润 | $18.6M | $14.2M |
| 毛利率 | 16.0% | 89.6% |
| 营业利润率 | 9.2% | 9.8% |
| 净利率 | 4.7% | 7.0% |
| 营收同比 | 28.9% | 65.0% |
| 净利润同比 | 178.8% | 259.8% |
| 每股收益（稀释后） | $0.43 | $0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $396.1M | $202.1M | ||
| Q3 25 | $227.5M | $180.9M | ||
| Q2 25 | $214.6M | $156.8M | ||
| Q1 25 | $494.6M | $137.8M | ||
| Q4 24 | $307.2M | $122.5M | ||
| Q3 24 | $208.8M | $112.2M | ||
| Q2 24 | $202.9M | $108.6M | ||
| Q1 24 | $364.0M | $79.9M |
| Q4 25 | $18.6M | $14.2M | ||
| Q3 25 | $-7.2M | $18.4M | ||
| Q2 25 | $-17.0M | $17.8M | ||
| Q1 25 | $-32.0M | $8.5M | ||
| Q4 24 | $-23.6M | $-8.9M | ||
| Q3 24 | $-48.3M | $-12.7M | ||
| Q2 24 | $-43.6M | $-3.9M | ||
| Q1 24 | $-38.9M | $-17.7M |
| Q4 25 | 16.0% | 89.6% | ||
| Q3 25 | 16.9% | 88.8% | ||
| Q2 25 | 19.2% | 88.1% | ||
| Q1 25 | 15.5% | 87.0% | ||
| Q4 24 | 11.2% | 85.4% | ||
| Q3 24 | 9.3% | 82.1% | ||
| Q2 24 | 16.1% | 88.7% | ||
| Q1 24 | 19.7% | 86.7% |
| Q4 25 | 9.2% | 9.8% | ||
| Q3 25 | 5.3% | 13.3% | ||
| Q2 25 | 7.4% | 12.9% | ||
| Q1 25 | -0.6% | 9.6% | ||
| Q4 24 | 0.2% | -15.7% | ||
| Q3 24 | -14.3% | -8.6% | ||
| Q2 24 | 2.9% | -0.1% | ||
| Q1 24 | -10.8% | -20.7% |
| Q4 25 | 4.7% | 7.0% | ||
| Q3 25 | -3.2% | 10.2% | ||
| Q2 25 | -7.9% | 11.4% | ||
| Q1 25 | -6.5% | 6.2% | ||
| Q4 24 | -7.7% | -7.3% | ||
| Q3 24 | -23.1% | -11.3% | ||
| Q2 24 | -21.5% | -3.6% | ||
| Q1 24 | -10.7% | -22.2% |
| Q4 25 | $0.43 | $0.18 | ||
| Q3 25 | — | $0.23 | ||
| Q2 25 | $-0.41 | $0.23 | ||
| Q1 25 | $-0.77 | $0.11 | ||
| Q4 24 | $-0.57 | $-0.11 | ||
| Q3 24 | $-1.17 | $-0.18 | ||
| Q2 24 | $-1.05 | $-0.06 | ||
| Q1 24 | $-0.94 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $46.7M | $414.1M |
| 总债务越低越好 | $890.0M | — |
| 股东权益账面价值 | $260.5M | $567.6M |
| 总资产 | $1.5B | $763.6M |
| 负债/权益比越低杠杆越低 | 3.42× | — |
8季度趋势，按日历期对齐
| Q4 25 | $46.7M | $414.1M | ||
| Q3 25 | $59.7M | $352.1M | ||
| Q2 25 | $79.4M | $307.8M | ||
| Q1 25 | $49.5M | $268.3M | ||
| Q4 24 | $45.8M | $243.6M | ||
| Q3 24 | $20.2M | $223.8M | ||
| Q2 24 | $12.8M | $218.8M | ||
| Q1 24 | $38.3M | $213.6M |
| Q4 25 | $890.0M | — | ||
| Q3 25 | $839.8M | — | ||
| Q2 25 | $833.4M | — | ||
| Q1 25 | $807.6M | — | ||
| Q4 24 | $974.4M | — | ||
| Q3 24 | $921.2M | — | ||
| Q2 24 | $875.1M | — | ||
| Q1 24 | $877.2M | — |
| Q4 25 | $260.5M | $567.6M | ||
| Q3 25 | $234.1M | $535.4M | ||
| Q2 25 | $249.8M | $495.0M | ||
| Q1 25 | $236.5M | $457.5M | ||
| Q4 24 | $263.0M | $438.4M | ||
| Q3 24 | $316.6M | $437.0M | ||
| Q2 24 | $352.1M | $435.1M | ||
| Q1 24 | $400.4M | $431.9M |
| Q4 25 | $1.5B | $763.6M | ||
| Q3 25 | $1.5B | $712.3M | ||
| Q2 25 | $1.5B | $661.1M | ||
| Q1 25 | $1.5B | $599.3M | ||
| Q4 24 | $1.7B | $580.6M | ||
| Q3 24 | $1.6B | $555.3M | ||
| Q2 24 | $1.6B | $542.4M | ||
| Q1 24 | $1.7B | $519.7M |
| Q4 25 | 3.42× | — | ||
| Q3 25 | 3.59× | — | ||
| Q2 25 | 3.34× | — | ||
| Q1 25 | 3.41× | — | ||
| Q4 24 | 3.70× | — | ||
| Q3 24 | 2.91× | — | ||
| Q2 24 | 2.49× | — | ||
| Q1 24 | 2.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.0M | $53.9M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $53.3M |
| 自由现金流率自由现金流/营收 | -15.1% | 26.4% |
| 资本支出强度资本支出/营收 | 5.8% | 0.3% |
| 现金转化率经营现金流/净利润 | -1.99× | 3.80× |
| 过去12个月自由现金流最近4个季度 | $94.1M | $136.4M |
8季度趋势，按日历期对齐
| Q4 25 | $-37.0M | $53.9M | ||
| Q3 25 | $-6.9M | $33.7M | ||
| Q2 25 | $21.8M | $28.1M | ||
| Q1 25 | $186.9M | $22.3M | ||
| Q4 24 | $-4.1M | $18.8M | ||
| Q3 24 | $-12.7M | $-2.2M | ||
| Q2 24 | $-6.8M | $5.2M | ||
| Q1 24 | $86.2M | $4.0M |
| Q4 25 | $-59.8M | $53.3M | ||
| Q3 25 | $-22.8M | $33.0M | ||
| Q2 25 | $3.8M | $27.9M | ||
| Q1 25 | $172.9M | $22.2M | ||
| Q4 24 | $-25.9M | $18.6M | ||
| Q3 24 | $-33.6M | — | ||
| Q2 24 | $-21.5M | — | ||
| Q1 24 | $56.2M | $3.9M |
| Q4 25 | -15.1% | 26.4% | ||
| Q3 25 | -10.0% | 18.2% | ||
| Q2 25 | 1.8% | 17.8% | ||
| Q1 25 | 35.0% | 16.1% | ||
| Q4 24 | -8.4% | 15.2% | ||
| Q3 24 | -16.1% | — | ||
| Q2 24 | -10.6% | — | ||
| Q1 24 | 15.4% | 4.9% |
| Q4 25 | 5.8% | 0.3% | ||
| Q3 25 | 7.0% | 0.4% | ||
| Q2 25 | 8.4% | 0.1% | ||
| Q1 25 | 2.8% | 0.1% | ||
| Q4 24 | 7.1% | 0.2% | ||
| Q3 24 | 10.0% | 0.0% | ||
| Q2 24 | 7.2% | 0.0% | ||
| Q1 24 | 8.2% | 0.1% |
| Q4 25 | -1.99× | 3.80× | ||
| Q3 25 | — | 1.83× | ||
| Q2 25 | — | 1.58× | ||
| Q1 25 | — | 2.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
KNSA
暂无分部数据
